These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 15561279)
61. A novel immunosuppressant, FTY720, increases the efficiency of a superantigen-induced peripheral T-cell deletion whilst inhibiting negative selection in the thymus. Shimizu C; Li X; Kimura M; Hashimoto K; Sugaya K; Kubo M; Suzuki S; Nakayama T Immunology; 1998 Aug; 94(4):503-12. PubMed ID: 9767438 [TBL] [Abstract][Full Text] [Related]
62. Effect of FTY720 in rat small bowel transplantation: expression of mucosal addressin cell adhesion molecule-1. Sugito K; Koshinaga T; Inoue M; Ikeda T; Hagiwara N; Fukuzawa M Transplant Proc; 2005 Dec; 37(10):4472-4. PubMed ID: 16387148 [TBL] [Abstract][Full Text] [Related]
63. Protective effects of FTY720 on chronic allograft nephropathy by reducing late lymphocytic infiltration. Wang M; Liu S; Ouyang N; Song E; Lutz J; Heemann U Kidney Int; 2004 Sep; 66(3):1248-56. PubMed ID: 15327424 [TBL] [Abstract][Full Text] [Related]
64. FTY720: placebo-controlled study of the effect on cardiac rate and rhythm in healthy subjects. Schmouder R; Serra D; Wang Y; Kovarik JM; DiMarco J; Hunt TL; Bastien MC J Clin Pharmacol; 2006 Aug; 46(8):895-904. PubMed ID: 16855074 [TBL] [Abstract][Full Text] [Related]
65. Control of intestinal allograft rejection by FTY720 and costimulation blockade. Yan S; Rodriguez-Barbosa JI; Pabst O; Beckmann JH; Brinkmann V; Förster R; Hoffmann MW Transplant Proc; 2005; 37(1):114-5. PubMed ID: 15808565 [TBL] [Abstract][Full Text] [Related]
66. Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice. Sumi T; Fukushima A; Nishino K; Fukuda K; Kumagai N; Nishida T; Ueno H Cell Biol Int; 2009 Apr; 33(4):534-41. PubMed ID: 19230848 [TBL] [Abstract][Full Text] [Related]
67. Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis. Foster CA; Howard LM; Schweitzer A; Persohn E; Hiestand PC; Balatoni B; Reuschel R; Beerli C; Schwartz M; Billich A J Pharmacol Exp Ther; 2007 Nov; 323(2):469-75. PubMed ID: 17682127 [TBL] [Abstract][Full Text] [Related]
69. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine. Roos M; Liu S; Strobl M; Schmaderer C; Baumann M; Heemann U; Lutz J Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477 [TBL] [Abstract][Full Text] [Related]
70. The perivascular space as a path of hematopoietic progenitor cells and mature T cells between the blood circulation and the thymic parenchyma. Mori K; Itoi M; Tsukamoto N; Kubo H; Amagai T Int Immunol; 2007 Jun; 19(6):745-53. PubMed ID: 17493961 [TBL] [Abstract][Full Text] [Related]
71. FTY720 attenuates accumulation of EMAP-II+ and MHC-II+ monocytes in early lesions of rat traumatic brain injury. Zhang Z; Zhang Z; Fauser U; Artelt M; Burnet M; Schluesener HJ J Cell Mol Med; 2007; 11(2):307-14. PubMed ID: 17488479 [TBL] [Abstract][Full Text] [Related]
72. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767 [TBL] [Abstract][Full Text] [Related]
73. Asymmetric synthesis and biological evaluation of the enantiomeric isomers of the immunosuppressive FTY720-phosphate. Kiuchi M; Adachi K; Tomatsu A; Chino M; Takeda S; Tanaka Y; Maeda Y; Sato N; Mitsutomi N; Sugahara K; Chiba K Bioorg Med Chem; 2005 Jan; 13(2):425-32. PubMed ID: 15598563 [TBL] [Abstract][Full Text] [Related]
74. Reduction of ischemia-reperfusion injury in the rat kidney by FTY720, a synthetic derivative of sphingosine. Delbridge MS; Shrestha BM; Raftery AT; El Nahas AM; Haylor JL Transplantation; 2007 Jul; 84(2):187-95. PubMed ID: 17667810 [TBL] [Abstract][Full Text] [Related]
75. Evaluation of the lymphocyte trafficking drug FTY720 in SHIVSF162P3-infected rhesus macaques. Kersh EN; Luo W; Adams DR; Mitchell J; Garcia-Lerma JG; Butera S; Folks T; Otten R J Antimicrob Chemother; 2009 Apr; 63(4):758-62. PubMed ID: 19218272 [TBL] [Abstract][Full Text] [Related]
76. Long-term effect of FTY720 on lymphocyte count and islet allograft survival in mice. Liu L; Wang C; He X; Shang W; Bi Y; Wang D Microsurgery; 2007; 27(4):300-4. PubMed ID: 17477424 [TBL] [Abstract][Full Text] [Related]
77. [Effect of cyclosporin on the thymus and spleen in rats]. Nagai Y Nihon Geka Gakkai Zasshi; 1988 Jun; 89(6):906-20. PubMed ID: 3185475 [TBL] [Abstract][Full Text] [Related]
78. The thymus reconstituted nude rat: lymphocyte subpopulations and immunological characteristics. Hougen HP; Klausen B Thymus; 1987; 10(3-4):207-17. PubMed ID: 3501184 [TBL] [Abstract][Full Text] [Related]
79. FTY720 improves survival after transient ischemia and reperfusion of the hind limbs. Frink M; Kaudel CP; Hildebrand F; Pape HC; Klempnauer J; Winkler M; Krettek C; van Griensven M J Trauma; 2007 Aug; 63(2):263-7. PubMed ID: 17693822 [TBL] [Abstract][Full Text] [Related]
80. Effect of Cyclosporin A on rat thymus: time course analysis by immunoperoxidase technique and flow cytofluorometry. Tanaka M; Shinohara K; Fukumoto T; Tanaka H; Kaneko T Clin Exp Immunol; 1988 May; 72(2):216-21. PubMed ID: 3044648 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]